APA

Buchberger B., Follmann M., Freyer D., Huppertz H., Ehm A. & Wasem J. (20120125). The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA). : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Chicago

Buchberger B, Follmann M, Freyer D, Huppertz H, Ehm A and Wasem J. 20120125. The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA). : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Harvard

Buchberger B., Follmann M., Freyer D., Huppertz H., Ehm A. and Wasem J. (20120125). The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA). : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

MLA

Buchberger B, Follmann M, Freyer D, Huppertz H, Ehm A and Wasem J. The evidence for the use of growth factors and active skin substitutes for the treatment of non-infected diabetic foot ulcers (DFU): a health technology assessment (HTA). : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 20120125.